Cargando…
Immobilisation of Delta-like 1 ligand for the scalable and controlled manufacture of hematopoietic progenitor cells in a stirred bioreactor
BACKGROUND: Umbilical cord blood provides a source of hematopoietic stem cells for transplantation with immunological and availability advantages over conventional bone marrow sources. Limited cell numbers and slower engraftment from umbilical cord blood units has led to the clinical development of...
Autores principales: | Moore, Rebecca L. L., Worrallo, Matthew J., Mitchell, Peter D., Harriman, Jon, Glen, Katie E., Thomas, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544980/ https://www.ncbi.nlm.nih.gov/pubmed/28778182 http://dx.doi.org/10.1186/s12896-017-0383-0 |
Ejemplares similares
-
The productivity limit of manufacturing blood cell therapy in scalable stirred bioreactors
por: Bayley, Rachel, et al.
Publicado: (2017) -
Enabling Allogeneic T Cell-Based Therapies: Scalable Stirred-Tank Bioreactor Mediated Manufacturing
por: Gatla, Himavanth, et al.
Publicado: (2022) -
Expansion and differentiation of ex vivo cultured erythroblasts in scalable stirred bioreactors
por: Gallego‐Murillo, Joan Sebastián, et al.
Publicado: (2022) -
Cell-Based Therapy Manufacturing in Stirred Suspension Bioreactor: Thoughts for cGMP Compliance
por: Nath, Suman C., et al.
Publicado: (2020) -
Optical stirring in a droplet cell bioreactor
por: Muradoglu, Murat, et al.
Publicado: (2012)